Citigroup
CYNA

Citigroup’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Citigroup’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17
Closed – – 7761
2016
Q1 		$0 Buy
+17
New +$228 ﹤0.01% 8055
2015
Q4 		– Sell
-7
Closed – – 8132
2015
Q3 		$0 Buy
+7
New +$114 ﹤0.01% 8090

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citigroup's CYNA Position: Q2 2016 in Review

Citigroup sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q2 2016, closing a stake of 17 shares.

Citigroup first reported a position in CYNA in Q3 2015 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 32 funds tracked by Wall St. Rank hold CYNA as of Q2 2016.

  • Citigroup reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 17 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q2 2016.
  • Citigroup first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2015 and held it in 2 quarters.
  • Citigroup's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $0 in Q1 2016.
  • 32 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.